{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:02:00Z","timestamp":1777330920511,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12877-015-0154-5","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T11:41:50Z","timestamp":1448970110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study"],"prefix":"10.1186","volume":"15","author":[{"given":"Sabine","family":"Ruths","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit S.","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette H.","family":"Ranhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steinar","family":"Hunskaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars B.","family":"Enges\u00e6ter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Engeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"154_CR1","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1046\/j.1532-5415.2002.50455.x","volume":"50","author":"CL Leibson","year":"2002","unstructured":"Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002;50:1644\u201350.","journal-title":"J Am Geriatr Soc"},{"key":"154_CR2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10654-009-9353-8","volume":"24","author":"LA Ahmed","year":"2009","unstructured":"Ahmed LA, Schirmer H, Bj\u00f8rnerem \u00c5, Emaus N, J\u00f8rgensen L, St\u00f8rmer J, et al. The gender- and age-specific 10-year and lifetime absolute fracture risk in Troms\u00f8, Norway. Eur J Epidemiol. 2009;24:441\u20138.","journal-title":"Eur J Epidemiol"},{"key":"154_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1532-5415.2011.03317.x","volume":"59","author":"A Gangavati","year":"2011","unstructured":"Gangavati A, Hajjar I, Quach L, Jones RN, Kiely DK, Gagnon P, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the Elderly of Boston Study. J Am Geriatr Soc. 2011;59:383\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"154_CR4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","volume":"354","author":"FP Cappuccio","year":"1999","unstructured":"Cappuccio FP, Meilahn E, Zmuda JM, Cauley ZA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 1999;354:971\u20135.","journal-title":"Lancet"},{"key":"154_CR5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.amjhyper.2004.08.016","volume":"18","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2005","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Mart\u00edn-Escudero JC, Alvarez Manzanares P, Cort\u00e9s Sancho R, Iglesias Zamora S, Garc\u00eda Alonso M. Hypertension as a risk factor for hip fracture. Am J Hypertens. 2005;18:146\u20137.","journal-title":"Am J Hypertens"},{"key":"154_CR6","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1001\/jama.2009.1463","volume":"302","author":"U Sennerby","year":"2009","unstructured":"Sennerby U, Melhus K, Gedeborg R, Byberg L, Garma H, Ahlbom A, et al. Cardiovascular diseases and risk of hip fractures. JAMA. 2009;302:1666\u201373.","journal-title":"JAMA"},{"key":"154_CR7","unstructured":"Norwegian Prescription Database [ http:\/\/norpd.no ]."},{"key":"154_CR8","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4045\/tidsskr.11.0984","volume":"132","author":"HS Blix","year":"2012","unstructured":"Blix HS, Landmark K, Selmer R, Reikvam A. Patterns in the prescription of antihypertensive drugs in Norway, 1975\u20132010. Tidsskr Nor Laegeforen. 2012;132:1224\u20138.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"154_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6963-5-21","volume":"5","author":"A Fretheim","year":"2005","unstructured":"Fretheim A, Oxman AD. International variation in prescribing antihypertensive drugs: its extent and possible explanations. BMC Health Serv Res. 2005;5:21.","journal-title":"BMC Health Serv Res"},{"key":"154_CR10","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00198-013-2369-7","volume":"24","author":"DA Butt","year":"2013","unstructured":"Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporos Int. 2013;24:2649\u201357.","journal-title":"Osteoporos Int"},{"key":"154_CR11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/2013.jamainternmed.469","volume":"172","author":"DA Butt","year":"2012","unstructured":"Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172:1739\u201344.","journal-title":"Arch Intern Med"},{"key":"154_CR12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00198-012-2053-3","volume":"24","author":"SD Berry","year":"2013","unstructured":"Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y. Diuretic initiation and the acute risk of hip fracture. Osteoporos Int. 2013;24:689\u201395.","journal-title":"Osteoporos Int"},{"key":"154_CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1532-5415.1999.tb01899.x","volume":"47","author":"RM Leipzig","year":"1999","unstructured":"Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis. II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47:40\u201350.","journal-title":"J Am Geriatr Soc"},{"key":"154_CR14","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"JC Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952\u201360.","journal-title":"Arch Intern Med"},{"key":"154_CR15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12020-014-0167-4","volume":"46","author":"M Ghosh","year":"2014","unstructured":"Ghosh M, Majundar SR. Antihypertensive medications, bone mineral density, and fractures: a review of cardiac drugs that provides new insights into osteoporosis. Endocrine. 2014;46:397\u2013405.","journal-title":"Endocrine"},{"key":"154_CR16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17453670810016588","volume":"79","author":"JE Gjertsen","year":"2008","unstructured":"Gjertsen JE, Engesaeter LB, Furnes O, Havelin LI, Steindal K, Vinje T, et al. The Norwegian Hip Fracture Register: experiences after the first 2 years and 15,576 reported operations. Acta Orthop. 2008;79:583\u201393.","journal-title":"Acta Orthop"},{"key":"154_CR17","unstructured":"Norwegian Central Population Registry [ http:\/\/www.skatteetaten.no\/en\/Person\/National-Registry\/?utm_source=1&utm_medium=flyttemelding&utm_campaign=folkeregisteret ]."},{"key":"154_CR18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ageing\/aft009","volume":"42","author":"MS Bakken","year":"2013","unstructured":"Bakken MS, Engeland A, Enges\u00e6ter LB, Ranhoff AH, Hunskaar S, Ruths S. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. Age Ageing. 2013;42:514\u201320.","journal-title":"Age Ageing"},{"key":"154_CR19","first-page":"129","volume":"18","author":"K Furu","year":"2008","unstructured":"Furu K. Establishment of the nationwide Norwegian Prescription Database. Nor J Epidemiol. 2008;18:129\u201336.","journal-title":"Nor J Epidemiol"},{"key":"154_CR20","unstructured":"The WHO Collaborating Centre for Drug Statistics Methodology [ http:\/\/www.whocc.no\/atc_ddd_index\/ ]."},{"key":"154_CR21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.annepidem.2007.03.009","volume":"17","author":"A Engeland","year":"2007","unstructured":"Engeland A, Skurtveit S, Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol. 2007;17:597\u2013602.","journal-title":"Ann Epidemiol"},{"key":"154_CR22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00228-003-0646-7","volume":"59","author":"HA Nygaard","year":"2003","unstructured":"Nygaard HA, Naik M, Ruths S, Straand J. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents. The Bergen district nursing home (BEDNURS) study. Eur J Clin Pharmacol. 2003;59:463\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"154_CR23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1359\/jbmr.080702","volume":"23","author":"K Rapp","year":"2008","unstructured":"Rapp K, Becker C, Lamb SE, Icks A, Klenk J. Hip fractures in institutionalized elderly people: incidence rates and excess mortality. J Bone Miner Res. 2008;23:1825\u201331.","journal-title":"J Bone Miner Res"},{"key":"154_CR24","unstructured":"Norwegian Arthroplasty Register. 2015. Annual report (2014) available from: http:\/\/nrlweb.ihelse.net."},{"key":"154_CR25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case\u2013control study. J Hypertens. 2006;24:581\u20139.","journal-title":"J Hypertens"},{"key":"154_CR26","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Mogun H, Garneau K, Fischer MA. Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res. 2011;26:1561\u20137.","journal-title":"J Bone Miner Res"},{"key":"154_CR27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00228-011-1014-7","volume":"67","author":"T Grimmsmann","year":"2011","unstructured":"Grimmsmann T, Himmel W. Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes? Eur J Clin Pharmacol. 2011;67:847\u201354.","journal-title":"Eur J Clin Pharmacol"},{"key":"154_CR28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of \u03b2-blockers and risk of fractures. JAMA. 2004;292:1326\u201332.","journal-title":"JAMA"},{"key":"154_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2318-14-131","volume":"14","author":"K Thorell","year":"2014","unstructured":"Thorell K, Ranstad K, Midl\u00f6v P, Borgquist L, Halling A. Is use of fall-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study. BMC Geriatr. 2014;14:131.","journal-title":"BMC Geriatr"},{"key":"154_CR30","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/jbmr.2271","volume":"29","author":"DA Butt","year":"2014","unstructured":"Butt DA, Mamdani M, Gomes T, Lix L, Lu H, Tu K. Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive community-dwelling elderly. J Bone Miner Res. 2014;29:2483\u20138.","journal-title":"J Bone Miner Res"},{"key":"154_CR31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ageing\/afq071","volume":"39","author":"R Peters","year":"2010","unstructured":"Peters R, Beckett N, Burch L, de Vernejoul MC, Liu L, Duggan J, et al. The effect of treatment based on a diuretic (indapamide)\u2009\u00b1\u2009ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET). Age Ageing. 2010;39:609\u201316.","journal-title":"Age Ageing"},{"key":"154_CR32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","volume":"38","author":"H Lynn","year":"2006","unstructured":"Lynn H, Kwok T, Wong SY, Woo J, Leung PC. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone. 2006;38:584\u20138.","journal-title":"Bone"},{"key":"154_CR33","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-011-1831-7","volume":"23","author":"T Kwok","year":"2012","unstructured":"Kwok T, Leung J, Zhang YF, Bauer D, Ensrud KE, Barrett-Connor E, et al. Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men? Osteoporos Int. 2012;23:2159\u201367.","journal-title":"Osteoporos Int"},{"key":"154_CR34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0895-7061(03)00845-8","volume":"16","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2003","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Silva J, Justo I, Sanz A, Mart\u00edn-Luquero M, Igea R, et al. Effect of quinapril, quinapril.-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphism. Am J Hypertens. 2003;16:453\u20139.","journal-title":"Am J Hypertens"},{"key":"154_CR35","doi-asserted-by":"crossref","unstructured":"Aoki M, Kawahata H, Sotobayashi D, Yu H, Moriguchi A, Nakagami H, et al. Effect of angiotensin II receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome. Geriatr Gerontol Int. 2014. doi: 10.1111\/ggi.12406 .","DOI":"10.1111\/ggi.12406"},{"key":"154_CR36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/hr.2009.99","volume":"32","author":"H Shimizu","year":"2009","unstructured":"Shimizu H, Nakagami H, Osako MK, Nakagami F, Kunugiza Y, Tomita T, et al. Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats. Hypertens Res. 2009;32:786\u201390.","journal-title":"Hypertens Res"},{"key":"154_CR37","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 2008;22:2465\u201375.","journal-title":"FASEB J"},{"key":"154_CR38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000335491","volume":"635","author":"I Gradosova","year":"2012","unstructured":"Gradosova I, Zivna H, Palicka V, Hubena S, Svejkovska K, Zivny P. Protective effect of amlodipine on rat bone tissue after orchidectomy. Pharmacology. 2012;635:37\u201343.","journal-title":"Pharmacology"},{"key":"154_CR39","first-page":"CD005185","volume":"10","author":"K Aung","year":"2011","unstructured":"Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev. 2011;10:CD005185.","journal-title":"Cochrane Database Syst Rev"},{"key":"154_CR40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9343(00)00510-6","volume":"109","author":"IR Reid","year":"2000","unstructured":"Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med. 2000;109:362\u201370.","journal-title":"Am J Med"},{"key":"154_CR41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-133-7-200010030-00010","volume":"133","author":"AZ LaCroix","year":"2000","unstructured":"LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133:516\u201326.","journal-title":"Ann Intern Med"},{"key":"154_CR42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1532-5415.2009.02195.x","volume":"57","author":"LS Lim","year":"2009","unstructured":"Lim LS, Fink HA, Blackwell T, Taylor BC, Ensrud KE. Loop diuretic use and rates of hip bone loss and risk of falls and fractures in older women. J Am Geriatr Soc. 2009;57:855\u201362.","journal-title":"J Am Geriatr Soc"},{"key":"154_CR43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1359\/JBMR.051003","volume":"21","author":"L Reinmark","year":"2006","unstructured":"Reinmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res. 2006;21:163\u201370.","journal-title":"J Bone Miner Res"},{"key":"154_CR44","doi-asserted-by":"crossref","unstructured":"Xiao F, Qu X, Zhai Z, Jiang C, Li H, Liu X, et al. Association between loop diuretic use and fracture risk. Osteoporos Int. 2014 Dec 10 [Epub ahead of print] DOI 10.1007\/s00198-014-2979-8 .","DOI":"10.1007\/s00198-014-2979-8"},{"key":"154_CR45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","volume":"259","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated with loop diuretics. J Int Med. 2006;259:117\u201324.","journal-title":"J Int Med"},{"key":"154_CR46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.168.7.735","volume":"168","author":"LS Lim","year":"2008","unstructured":"Lim LS, Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Ensrud KE. Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med. 2008;168:735\u201340.","journal-title":"Arch Intern Med"},{"key":"154_CR47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.maturitas.2013.02.007","volume":"75","author":"S Arampatzis","year":"2013","unstructured":"Arampatzis S, Gaetcke LM, Funk GC, Schwarz C, Mohaupt M, Zimmermann H, et al. Diuretic-induced hyponatremia and osteoporotic fractures in patients admitted to the emergency department. Maturitas. 2013;75:81\u20136.","journal-title":"Maturitas"},{"key":"154_CR48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bone.2012.07.013","volume":"51","author":"S Yang","year":"2012","unstructured":"Yang S, Nguyen ND, Eisman JA, Nguyen TV. Association between beta-blockers and fracture risk: a Bayesian meta-analysis. Bone. 2012;51:969\u201374.","journal-title":"Bone"},{"key":"154_CR49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00198-013-2498-z","volume":"25","author":"KA Toulis","year":"2014","unstructured":"Toulis KA, Hemming K, Stergianos S, Nirantharakumar K, Bilezikian JP. \u03b2-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects. Osteoporos Int. 2014;25:121\u20139.","journal-title":"Osteoporos Int"},{"key":"154_CR50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.0301214","volume":"19","author":"JA Pasco","year":"2004","unstructured":"Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res. 2004;19:19\u201324.","journal-title":"J Bone Miner Res"},{"key":"154_CR51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/JBMR.041202","volume":"20","author":"IR Reid","year":"2005","unstructured":"Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, et al. Beta-blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res. 2005;20:613\u20138.","journal-title":"J Bone Miner Res"},{"key":"154_CR52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bone.2010.10.170","volume":"48","author":"S Yang","year":"2011","unstructured":"Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV. Association between beta-blockers and fracture risk: the Dubbo Osteoporosis Epidemiology Study. Bone. 2011;48:451\u20135.","journal-title":"Bone"},{"key":"154_CR53","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bone.2012.08.126","volume":"51","author":"HJ Song","year":"2012","unstructured":"Song HJ, Lee J, Kim YJ, Jung SY, Kim HJ, Choi NK, et al. \u03b21 selectivity of \u03b2-blockers and reduced risk of fractures in elderly hypertension patients. Bone. 2012;51:1008\u201315.","journal-title":"Bone"},{"key":"154_CR54","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1476-5381.2011.01686.x","volume":"165","author":"WF Rodrigues","year":"2012","unstructured":"Rodrigues WF, Madeira MF, da Silva TA, Clemente-Napimoga JT, Miguel CB, Dias-da-Silva VJ, et al. Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. Br J Pharmacol. 2012;165:2140\u201351.","journal-title":"Br J Pharmacol"},{"key":"154_CR55","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jgs.12925","volume":"62","author":"ML Callisaya","year":"2014","unstructured":"Callisaya ML, Sharman JE, Close J, Lord SR, Srikanth VK. Greater daily defined dose of antihypertensive medication increases the risk of falls in older people\u2014A population-based study. J Am Geriatr Soc. 2014;62:1527\u201333.","journal-title":"J Am Geriatr Soc"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-015-0154-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:47:23Z","timestamp":1498265243000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2318\/15\/153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["154"],"URL":"https:\/\/doi.org\/10.1186\/s12877-015-0154-5","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"153"}}